This inventor holds 1 USPTO granted patent. Top assignee: Hanmi Pharm. Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Min Young Kim: Innovator in Long-Acting Conjugates
Introduction
Min Young Kim is a notable inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. His work focuses on enhancing the efficacy and duration of therapeutic agents.
Latest Patents
Min Young Kim holds a patent for "LONG-ACTING CONJUGATES OF GLP-2 DERIVATIVES." This invention aims to improve the delivery and effectiveness of GLP-2 derivatives, which are crucial in various therapeutic applications. His innovative approach has the potential to transform treatment protocols in the medical field.
Career Highlights
Currently, Min Young Kim is employed at Hanmi Pharmaceutical Co., Ltd. His role at the company allows him to engage in cutting-edge research and development, contributing to the advancement of pharmaceutical sciences. His expertise and dedication have positioned him as a key player in his field.
Collaborations
Min Young Kim collaborates with talented colleagues, including Jaehyuk Choi and In Young Choi. Together, they work on various projects that aim to push the boundaries of pharmaceutical innovation.
Conclusion
Min Young Kim's contributions to the field of pharmaceuticals, particularly through his patent on long-acting conjugates, highlight his role as an influential inventor. His work continues to pave the way for advancements in drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile